WHO ICTRP trial

Prospective cohort study of compound cantharis gum / Huachansu capsule and…

ChiCTR-OCH-14004683 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR-OCH-14004683
Public title Prospective cohort study of compound cantharis gum / Huachansu capsule and Biejia decoction combined with traditional Chinese medicine intervention in primary liver cancer
Scientific title Prospective cohort study of compound cantharis gum / Huachansu capsule and Biejia decoction combined with traditional Chinese medicine intervention in primary liver cancer
Primary sponsor Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Observational study
Phase I (Phase I study)
Countries china
Conditions Liver cancer;C22.0 M-8170/3
Interventions Treatment group A:Medicine of doctor of traditional Chinese Medicine;Treatment group B:Medicine of doctor of traditional Chinese Medicine;Western medicine therapy group:Medicine of doctor of traditional Chinese Medicine
Registration date May 22, 2014
Target size Treatment group A:30;Treatment group B:30;Western medicine therapy group:30
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations